Am I correct in thinking that this drug, if it pans out, would potentially be effective for most people with PD, since it is designed to remove alpha synuclein from the brain? No matter how one acquired PD, toxic chemical exposure, gut dybiosis, genetic ddefect, head trauma etc., an aggegation of alpha synuclean in the brain results in PD.
If all trial phases are favorable, how long do we have to wait before this drug is available? Thanks